Skip to content

The Effect of Respiratory Muscle Training for Patients With COPD and Mild Cognitive Impairment

The Therapeutic Effect of Inspiratory and Expiratory Muscle Strengthening Training on Patients With COPD and Mild Cognitive Impairment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04929990
Enrollment
70
Registered
2021-06-18
Start date
2018-08-07
Completion date
2021-06-02
Last updated
2021-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Mild Cognitive Impairment

Brief summary

Patients with COPD and MCI received either inspiratory muscle training or inspiratory plus expiratory muscle training and compared the therapeutic effects

Detailed description

Patients with COPD and MCI were recruited, and were randomly assigned to the experimental group and the control group. The experimental group consisted of EMT and IMT for a total of 8 weeks, while the control group received IMT only. Outcomes measured and compared in this cohort were diaphragmatic thickness fraction and excursion examined by ultrasound, the dyspnea score of modified Medical Research Council (mMRC), the cognitive score of Mini-Mental State Examination (MMSE), and the score of COPD Assessment Test (CAT). In addition, the pulmonary function test, the cardiopulmonary exercise test, and the physiology performance of six minute walking test were also obtained. We also analyzed the difference of each parameters before and after training in each patient.

Interventions

BEHAVIORALRespiratory muscle training

Inspiratory and expiratory muscle training were performed using a breathing trainer (Dofin DT11/14, Galemed Co. Ltd, Taiwan) for 30 minutes a day with a total of eight weeks. Before the training, the MIP and maximal expiratory pressure (MEP) were documented by the best performance of three trials with a digital pressure gauge (GB60, Jitto International Co. Ltd, Taiwan)

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 1\. Having definite diagnosis of COPD, namely the value of the FEV1 divided by forced vital capacity (FVC) 10 to 15 minutes after beta-2 agonist inhalation being less than 0.7. * 2\. The score of Mini-Mental State Examination (MMSE) being between 23 and 27

Exclusion criteria

* 1\. Being not able to follow instructions on respiratory muscle training or complete the questionnaires of our study due to cognitive impairment. * 2\. Having difficulty to complete the cardiopulmonary exercise testing or the six minute walking test (6MWT) due to high risk cardiopulmonary diseases or other orthopedic conditions. * 3\. Having the diagnosis of lung cancer or history of receiving thoracoabdominal surgery * 4\. Having Body Mass Index more than 30

Design outcomes

Primary

MeasureTime frameDescription
MMSE8 weeksMini-Mental State Examination

Secondary

MeasureTime frameDescription
chronic obstructive pulmonary disease assessment test (CAT)8 weeksquestionnaire of dyspnea
diffusing capacity of the lung for carbon monoxide (DLCO)8 weeksdiffusing capacity of the lung for carbon monoxide (DLCO) in pulmonary function test
dead space fraction (Vd/Vt)8 weeksdead space fraction (Vd/Vt) in cardiopulmonary function test
the distance walked in 6 minutes8 weeksthe distance walked in 6 minutes
Diaphragmatic excursion8 weeksDiaphragmatic excursion on ultrasonography
forced vital capacity8 weeksforced vital capacity tested in pulmonary function test
Diaphragmatic thickness fraction8 weeksDiaphragmatic thickness fraction on ultrasonography
forced expiratory volume in 1 second divided by forced vital capacity8 weeksforced expiratory volume in 1 second divided by forced vital capacity in pulmonary function test
DLCO divided by alveolar volume (VA)8 weeksDLCO divided by alveolar volume (VA) in pulmonary function test
modified Medical Research Council (mMRC)8 weeksquestionnaire of dyspnea
minute ventilation to carbon dioxide output (VE/VCO2) slope8 weeksminute ventilation to carbon dioxide output (VE/VCO2) slope in cardiopulmonary function test
the change of oxygen saturation in 6 minutes walking test8 weeksthe change of oxygen saturation in 6 minutes walking test
the change of Borg scale in 6 minutes walking test8 weeksthe change of Borg scale in 6 minutes walking test
forced expiratory volume in 1 second8 weeksforced expiratory volume in 1 second in pulmonary function test

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026